Yüklüyor......
Relative Dose Intensity of Induction-Phase Pazopanib Treatment of Soft Tissue Sarcoma: Its Relationship with Prognoses of Pazopanib Responders
The approved standard dose of pazopanib is 800 mg per day, but the appropriate dose of pazopanib to treat soft tissue sarcoma (STS) patients in real-world practice is controversial. Of 124 STS patients treated with pazopanib, we retrospectively analyzed the cases of STS patients who achieved progres...
Kaydedildi:
| Yayımlandı: | J Clin Med |
|---|---|
| Asıl Yazarlar: | , , , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
MDPI
2019
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6352274/ https://ncbi.nlm.nih.gov/pubmed/30626115 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/jcm8010060 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|